A Phase 4 interventional study of hydrocortisone and Betamethasone in Phimosis, sponsored by Chelsea and Westminster NHS Foundation Trust. Withdrawn at 1 site in United Kingdom. Open to male participants aged 2 Years to 16 Years. Per ClinicalTrials.gov, last updated 2015-07-30.
Sponsored by Chelsea and Westminster NHS Foundation Trust · Phase 4, Interventional, and Treatment
Topical steroids are used as treatment for non-retractile foreskin in children for decades, but, there are disagreement among physicians about the optimum potency of the agent used. This study is designed to determine any difference in the beneficial effects of mild versus potent topical corticosteroids in treatment of non-retractile foreskin in children.
Chelsea and Westminster NHS Foundation Trust is the lead sponsor of 53 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
1%hydrocortisone for 8 weeks
Drug: hydrocortisone
Drug: Betamethasone
1%hydrocortisone topical once daily for 8 weeks
Betamethasone 0.1% topical once daily for 8weeks
Achievement of fully retractile foreskin with full exposure of glans at the end of therapy
Time frame: 16 weeks
Complications of topical corticosteroids
Time frame: 16 weeks
This study is withdrawn, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Phimosis
Chelsea and Westminster NHS Foundation Trust